CD109 and cancer: Furthermore, CD109’s potential involvement in the IL-6/GP130/STAT3 axis, a key driver of chronic inflammation and cancer stem cell survival, suggests it may help sustain an inflammatory environment that fosters metastasis and immune evasion (120, 121).